Sept. 9, 2026 Sphere 3D Corp. d/b/a DarkHorse Technologies (NASDAQ: ANY) enters Wednesday’s trading session in focus after shares surged in after-hours trading Tuesday following major strategic developments aimed at…
September 8, 2026 VivoSim Labs, Inc. (NASDAQ: VIVS) is targeting one of pharmaceutical development’s most expensive challenges: identifying drug toxicity before a candidate reaches human clinical trials. Using its NAMkind™…
Sept. 8, 2026 Mobix Labs Inc. (NASDAQ: MOBX) and Peraso Inc. (NASDAQ: PRSO) are gaining attention across the expanding defense technology market, with Mobix Labs securing its initial production order…
September 4 2026 — With spot gold trading near $4,475 per ounce, investor attention continues shifting toward mining, critical-mineral and advanced-material companies whose projects may provide leveraged exposure to rising…
As artificial intelligence moves from experimentation toward large-scale deployment, investor attention is expanding beyond software developers and semiconductor leaders to the physical infrastructure required to keep the digital economy running.…
Emerging-growth stocks bioAffinity Technologies, Inc. (NASDAQ: BIAF), AEye, Inc. (NASDAQ: LIDR), Sono Group N.V. (NASDAQ: SSM), and Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) are in focus following developments…
NEW YORK, September 1, 2026 — Micro-cap and emerging-growth stocks GoPro, Inc. (NASDAQ: GPRO), Fly-E Group, Inc. (NASDAQ: FLYE), Cellyan Biotechnology Co., Ltd. (NASDAQ: HKPD) and VivoSim Labs, Inc. (NASDAQ:…
Aug. 31, 2026 Emerging-growth companies spanning Physical AI, wearable robotics, livestreaming e-commerce, AI infrastructure, data centers, GPU computing and digital assets are drawing investor attention as companies pursue opportunities tied…
Aug. 31, 2026 — Several small-cap stocks are drawing investor attention following new corporate developments spanning biotechnology, military robotics, real estate and AI-enabled travel, with RedHill Biopharma Ltd. (NASDAQ: RDHL),…
POTOMAC, Md. – August 31, 2026 – IGC Pharma, Inc. (NYSE: IGC) is gaining attention after Ascendiant Capital Markets raised its 12-month price target to $6.00 from $5.50 while maintaining…
